ABIOMED Aktie [Valor: 903092 / ISIN: US0036541003]

Kaufen

Verkaufen

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen
			Ausblick

Kurse + Charts + Realtime
Kurs + Chart
Chart (gross)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen
Ausblick

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Strukturierte Produkte

Nachrichten zu ABIOMED Inc.

18.01.19	3 Reasons Growth Investors Will Love Abiomed (ABMD) (Zacks)
16.01.19	Abiomed (ABMD) Stock Sinks As Market Gains: What You Should Know (Zacks)
15.01.19	Why Abiomed Stock Gained 73.4% in 2018 (MotleyFool)
08.01.19	Abiomed (ABMD) Outpaces Stock Market Gains: What You Should Know (Zacks)
28.12.18	Abiomed (ABMD) Gains As Market Dips: What You Should Know (Zacks)
17.12.18	Has ABIOMED (ABMD) Outpaced Other Medical Stocks This Year? (Zacks)
13.12.18	Better Buy: Align Technology vs. Abiomed (MotleyFool)
13.12.18	Better Buy: Align Technology vs. Abiomed (FOX Business)
12.12.18	Abiomed (ABMD) Outpaces Stock Market Gains: What You Should Know (Zacks)
30.11.18	Abiomed (ABMD) Gains But Lags Market: What You Should Know (Zacks)
26.11.18	Here's Why You Should Invest in Abiomed (ABMD) Right Now (Zacks)
20.11.18	Time to Focus on ABIOMED (ABMD) for Strong Earnings Growth Potential (Zacks)
16.11.18	Abiomed (ABMD) Stock Sinks As Market Gains: What You Should Know (Zacks)
13.11.18	Has ABIOMED (ABMD) Outpaced Other Medical Stocks This Year? (Zacks)
12.11.18	Why Abiomed Plunged Today (MotleyFool)
11.11.18	Amazon Joins Eli Lilly And Abiomed As Strong Buys (Forbes)
09.11.18	ABIOMED (ABMD) Shares March Higher, Can It Continue? (Zacks)
06.11.18	Abiomed (ABMD) Stock Sinks As Market Gains: What You Should Know (Zacks)
04.11.18	Abiomed And Eli Lilly Emerge As Market Leaders (Forbes)
02.11.18	Abiomed (ABMD) Q2 Earnings Beat, Impella Maintains Momentum (Zacks)
02.11.18	Abiomed Pumps Out Triple-Digit Profit Growth and Boosts Guidance (Again) (MotleyFool)
01.11.18	Abiomed Inc (ABMD) Q2 2019 Earnings Conference Call Transcript (MotleyFool)
01.11.18	Top-Rated Medtech Abiomed Pops On Street-Topping Quarter (Investors Business Daily)
01.11.18	ABIOMED, Inc. : Abiomed Announces Q2 FY 2019 Record Revenue of $182 Million, up 37% Over Prior Year (Investegate)
30.10.18	Ausblick: ABIOMED mit Zahlen zum abgelaufenen Quartal (finanzen.net)
26.10.18	Abiomed (ABMD) Stock Moves -0.83%: What You Should Know (Zacks)
26.10.18	Zacks.com featured highlights include: ABIOMED, Inogen, Turtle Beach, MCBC and Rush Enterprises (Zacks)
25.10.18	Abiomed (ABMD) Q2 Earnings Preview: What to Look Out For (Zacks)
25.10.18	Is ABIOMED (ABMD) Outperforming Other Medical Stocks This Year? (Zacks)
18.10.18	Abiomed (ABMD) Stock Moves -0.81%: What You Should Know (Zacks)
11.10.18	Why Abiomed Stock Jumped 10.6% in September -- and Is Down 16.6% in October (FOX Business)
11.10.18	Why Abiomed Stock Jumped 10.6% in September -- and Is Down 16.6% in October (MotleyFool)
04.09.18	Here's Why You Should Hold on to Abiomed (ABMD) for Now (Zacks)
27.08.18	The Motley Fool Sits Down With Abiomed (FOX Business)
27.08.18	The Motley Fool Sits Down With Abiomed (MotleyFool)
30.07.18	Is ABIOMED (ABMD) Stock Outpacing Its Medical Peers This Year? (Zacks)
30.07.18	Abiomed Gets CDSCO Nod for Impella Heart Pumps in India (Zacks)
27.07.18	Abiomed Continues Its Strong Results (MotleyFool)
27.07.18	Abiomed (ABMD) Lags Q1 Earnings Estimates, Raises '19 View (Zacks)
26.07.18	Why Abiomed Inc. Stock Is Sinking Today (MotleyFool)
26.07.18	Abiomed (ABMD) Q1 Earnings Lag Estimates (Zacks)
26.07.18	Abiomed Earnings Miss Estimates, Stock Falls (Investors Business Daily)
26.07.18	Abiomed : Abiomed Announces Q1 FY 2019 Record Revenue of ... (Investegate)
24.07.18	Abiomed: Anleger-Herzen schlagen höher (Der Aktionär)
03.07.18	The Zacks Analyst Blog Highlights: ABIOMED, Lululemon, Insperity, DMC and Ensign (Zacks)
27.06.18	Has ABIOMED (ABMD) Outpaced Other Medical Stocks This Year? (Zacks)
27.06.18	Time to Focus on ABIOMED (ABMD) for Strong Earnings Growth Potential (Zacks)
11.06.18	Is ABIOMED (ABMD) Stock Outpacing Its Medical Peers This Year? (Zacks)
06.06.18	Here's Why You Should Buy Abiomed (ABMD) Stock Right Now (Zacks)
04.06.18	Why Is ABIOMED (ABMD) Up 13.6% Since Its Last Earnings Report? (Zacks)

1 | Weiter

Newssuche

Sika

135.50

3.83 %

Long

Short

Geberit

386.10

2.58 %

Long

Short

CieFinRichemont

68.80

2.50 %

Long

Short

Julius Baer Grp

40.79

2.41 %

Long

Short

LafargeHolcim

47.50

2.33 %

Long

Short

Novartis

88.80

0.89 %

Long

Short

Nestle

84.40

0.55 %

Long

Short

Roche Hldg G

258.40

0.49 %

Long

Short

Lonza Grp

277.50

0.29 %

Long

Short

Swisscom

488.70

0.12 %

Long

Short

mehr

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
Valor / ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:
Kaufwert:	CHF
	Hinzufügen Speichern

ABIOMED Aktie [Valor: 903092 / ISIN: US0036541003]

Nachrichten zu ABIOMED Inc.

Eintrag hinzufügen Eintrag bearbeiten

Newssuche

Aktien Top Flop

Meistgelesene Nachrichten